Delivery Order SPE2DB20D3505-SPE2DB22FT6M6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.56, is for the delivery of Pylera Capsules and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pylera Capsule pharmaceutical products, with a ceiling value of $6,341.38 and a completion date of February 24, 2022. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is valued at $2,039.76 for the delivery of Pylera Capsules. The contract has a firm fixed price and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,819.31 for the supply of 4558206944 PYLERA CAPSULE UU 120S. The contract has an ultimate completion date of August 25, 2022 and is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order valued at $2,141.88 and issued by the Defense Logistics Agency (DLA). The contract is for the supply of PYLERA CAPSULE UU 120S and has an ultimate completion date of January 31, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,856.19 to AmerisourceBergen Drug Corp for PYLERA Capsule UU 120S (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride), an antibiotic combination therapy. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on January 14, 2026, with an ultimate completion date of January 15, 2026. The award will be performed at AmerisourceBergen's corporate...
- This federal contract award is for the delivery of 16,000 unit capsules of the pharmaceutical product Pertzye DR to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $21,590.09 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $24,555.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 24,000 units of the drug PERTZYE DR 24,000 UNIT CAPSULE. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,011.70 firm fixed-price delivery order is for the supply of 24,000 units of the prescription medication PERTZYE DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,452.41 firm fixed-price delivery order is for the supply of 4562731597 - PIRFENIDONE 267 MG TABLET 270S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT6M6Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pylera capsules. The contract, valued at $3,595.47, is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in pharmaceutical distribution and the provision of medical supplies to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 4/6/22 |